Drug Type Small molecule drug |
Synonyms Caffenelin, 원라인세미정, 카펜에린정 |
Action agonists, antagonists, inhibitors |
Mechanism A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists), Adenosine receptor antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (01 Oct 2021), |
Regulation- |
Molecular FormulaC10H16ClNO |
InChIKeyBALXUFOVQVENIU-GNAZCLTHSA-N |
CAS Registry50-98-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | South Korea | 01 Oct 2021 |